Overview
Anthem
Health benefits provider Elevance Health, through a number of subsidiaries, provides health coverage to approximately 45.7 million members in the US. One of the nation's largest health insurers, Elavance Health is a Blue Cross and Blue Shield Association licensee in about 15 states (where it operates as Anthem Blue Cross, Anthem Blue Cross and Blue Shield) and provides non-BCBS plans under the Amerigroup, MMM, Simply Healthcare and/or Wellpoint. Through
...
Read More various subsidiaries, the company also offers pharmacy services through its CarelonRx business, and other healthcare related services as Carelon Insights, Carelon Health, Carelon Behavioral Health.
Read Less
Read More various subsidiaries, the company also offers pharmacy services through its CarelonRx business, and other healthcare related services as Carelon Insights, Carelon Health, Carelon Behavioral Health.
Read Less
#
20
Fortune 1000 Revenue Rank
Gail K Boudreaux
See more contacts
Insurance Carriers
,
Insurance Carriers and Related Activities
,
Finance and Insurance
,
Health insurance carriers
,
Dental insurance
Activities Related to Credit Intermediation
,
Agencies, Brokerages, and Other Insurance Related Activities
,
Depository Credit Intermediation
,
Insurance and Employee Benefit Funds
,
Monetary Authorities-Central Bank
,
Nondepository Credit Intermediation
,
Other Financial Investment Activities
,
Other Investment Pools and Funds
View more , Securities and Commodity Contracts Intermediation and Brokerage Securities and Commodity Exchanges
View fewer
View more , Securities and Commodity Contracts Intermediation and Brokerage Securities and Commodity Exchanges
View fewer
?
?
?
Actual
?
Actual
$177.01 billion
Actual
3.19%
-0.12%
$116,889
DEC
?
?
NYSE:ELV
Contacts
Get in Touch with 5 Principals* and 15,096 Contacts
-
Gail K BoudreauxPresident and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$177.01 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $5,808 | $8,061 | $8,399 |
| Net Investing Cash | -$5,167 | -$5,572 | -$4,560 |
| Net Financing Cash | $1,193 | -$3,349 | -$1,318 |
| Net Change in Cash | $1,834 | -$860 | $2,521 |
| Cash at Beginning of Period | $6,526 | $7,387 | $4,880 |
| Cash at End of Period | $8,288 | $6,526 | $7,387 |
| Capital Expenditure | -$1,256 | -$1,296 | -$1,152 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $8,288 | $6,526 | $7,387 |
| Accounts Receivable | $8,011 | $7,902 | $7,083 |
| Inventories | $ | $ | $ |
| Other Current Assets | $ | $ | $ |
| Asset Summary | |||
| Total Current Assets | $ | $ | $ |
| Tangible Fixed Assets | $4,652 | $4,359 | $4,316 |
| Intangible Assets | $12,094 | $10,273 | $10,315 |
| Total Assets | $116,889 | $108,928 | $102,755 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $22,673 | $23,021 | $21,203 |
| Short-Term Debt | $2,014 | $1,874 | $1,765 |
| Other Current Liabilities | $ | $ | $ |
| Liability Summary | |||
| Total Current Liabilities | $ | $ | $ |
| Long-Term Debt | $29,218 | $23,246 | $22,349 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $75,463 | $69,523 | $66,425 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $2 | $2 | $2 |
| Retained Earnings | $33,549 | $31,749 | $29,647 |
| Equity Summary | |||
| Total Equity | $41,315 | $39,306 | $36,243 |
| Shares Outstanding | 227,479,695 | 233,071,088 | 237,958,067 |